211 related articles for article (PubMed ID: 16385627)
21. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
22. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
Buchanan RM; Arulanandam BP; Metzger DW
J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
[TBL] [Abstract][Full Text] [Related]
23. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I
Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096
[TBL] [Abstract][Full Text] [Related]
24. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
[TBL] [Abstract][Full Text] [Related]
25. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
27. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.
Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM
Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057
[TBL] [Abstract][Full Text] [Related]
28. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity.
Sun HX; Wang H; Xu HS; Ni Y
Vaccine; 2009 Jun; 27(30):3984-91. PubMed ID: 19389450
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
30. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
[TBL] [Abstract][Full Text] [Related]
31. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
32. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles.
Sudheesh MS; Vyas SP; Kohli DV
Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824
[TBL] [Abstract][Full Text] [Related]
34. Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Imune vaccine.
Garg M; Kaplan AM; Bondada S
J Immunol; 1994 Feb; 152(4):1589-96. PubMed ID: 8120372
[TBL] [Abstract][Full Text] [Related]
35. Limitations of in vivo IL-12 supplementation strategies to induce Th1 early life responses to model viral and bacterial vaccine antigens.
Kovarik J; Martinez X; Pihlgren M; Bozzotti P; Tao MH; Kipps TJ; Wild TF; Lambert PH; Siegrist CA
Virology; 2000 Mar; 268(1):122-31. PubMed ID: 10683334
[TBL] [Abstract][Full Text] [Related]
36. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses.
Adkins B; Du RQ
J Immunol; 1998 May; 160(9):4217-24. PubMed ID: 9574522
[TBL] [Abstract][Full Text] [Related]
37. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
[TBL] [Abstract][Full Text] [Related]
38. Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.
Olafsdottir TA; Hannesdottir SG; Giudice GD; Trannoy E; Jonsdottir I
Scand J Immunol; 2007 Oct; 66(4):426-34. PubMed ID: 17850587
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
[TBL] [Abstract][Full Text] [Related]
40. The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.
Bjarnarson SP; Jakobsen H; Del Giudice G; Trannoy E; Siegrist CA; Jonsdottir I
Eur J Immunol; 2005 Apr; 35(4):1037-45. PubMed ID: 15756644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
